EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

2-O, 3-O Desulfated Heparin (ODSH) Preserves Endothelial Barrier Integrity in Lipopolysaccharide-Induced Acute Lung Injury by Modulating TLR4–MyD88–NF-κB Signaling

Rahul S Patil iD, Shweta R Patil iD, Liselle Simon, Peter Biggs, Latika Jaiswal, Basmah Mohamed, Thomas P Kennedy, Joyce Gonzales, Alexander D Verin iD

Biomolecules · 2026

DOI: 10.3390/biom16101516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Rahul S Patil und 8 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA. Hauptthemen laut MEDLINE: Acute Lung Injury, Toll-Like Receptor 4, Signal Transduction, NF-kappa B. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Augusta University, American Heart Association, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial lipopolysaccharide (LPS) disrupts endothelial barrier stability by inducing inflammatory events that underlie acute lung injury (ALI). Effective pharmacologic therapies capable of modifying the disease mechanisms of ALI remain limited. We previously demonstrated that 2-O, 3-O desulfated heparin (ODSH), a modified heparin with minimal anticoagulant activity and anti-inflammatory properties, attenuates LPS-induced ALI in mice and preserves human lung microvascular endothelial cell (HLMVEC) barrier integrity. In the present study, we further investigated the mechanisms of ODSH-mediated protection in mice and HLMVECs, focusing on inflammatory mediator expression and the modulation of TLR4–MyD88–NF-κB signaling. HLMVECs were pretreated with ODSH before LPS exposure, and barrier function was monitored using transendothelial electrical resistance measurements. Complementary experiments were performed in CD-1 mice receiving intratracheal LPS with or without intravenous ODSH. Across both models, ODSH attenuated LPS-induced endothelial barrier dysfunction. ODSH significantly reduced bronchoalveolar lavage fluid (BALF) protein accumulation, inflammatory cell infiltration, IL-6 and TNF-α concentrations, Evans Blue dye extravasation, and pulmonary edema. Gene expression analyses demonstrated that ODSH suppressed multiple pro-inflammatory mediators and inflammatory signaling components, including IL-1β, TNF-α, IL-6, NOS2, MAPK14, MAPK1, ICAM1, and CCL2, while enhancing IL-10 and several barrier-associated genes (CDH5, OCLN, CLDN5, and TJP1). ODSH also reduced the mRNA expression of TLR4, MYD88, and RELA. Protein analyses confirmed a reduced expression of NF-κB, MyD88, and TNF-α. Furthermore, ODSH at concentrations of 5–100 μg/mL did not significantly affect cellular metabolic activity. Collectively, these findings indicate that ODSH preserves endothelial barrier function and attenuates inflammatory responses associated with TLR4–MyD88–NF-κB signaling in experimental ALI. The findings support the further mechanistic and preclinical investigation of ODSH in inflammatory lung injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryToll-Like Receptor 4Signal TransductionNF-kappa BMyeloid Differentiation Factor 88HeparinAnimalsLipopolysaccharidesMiceHumansMaleEndothelial CellsLung

Stichwörter der Autor:innen

2-O, 3-O desulfated heparinacute lung injurycytokinesendothelial permeabilitylipopolysaccharide

Substanzen

Toll-Like Receptor 4LipopolysaccharidesNF-kappa BMyeloid Differentiation Factor 88Heparinheparin, O-desulfatedTlr4 protein, mouseMyd88 protein, mouse

Autor:innen und Institutionen

  • Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
  • Cantex Pharmaceuticals Inc., Weston, FL 33326, USA.
  • GlycoMira Therapeutics, Salt Lake City, UT 84108, USA.
  • Department of Medicine, Division of Pulmonary Medicine, Wake Forest University, Winston-Salem, NC 27157, USA.
  • Division of Pulmonary, Critical Care, and Sleep Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.

ORCID-Profile: Rahul S Patil, Shweta R Patil, Alexander D Verin

Förderung

  • Augusta University
  • American Heart Association
  • NHLBI NIH HHS
  • NIH/National Heart, Lung, and Blood Institute

Zitieren

APA

Patil, R. S., Patil, S. R., Simon, L., Biggs, P., Jaiswal, L., Mohamed, B., Kennedy, T. P., Gonzales, J., & Verin, A. D. (2026). 2-O, 3-O Desulfated Heparin (ODSH) Preserves Endothelial Barrier Integrity in Lipopolysaccharide-Induced Acute Lung Injury by Modulating TLR4–MyD88–NF-κB Signaling. Biomolecules. https://doi.org/10.3390/biom16101516

Vancouver

Patil RS, Patil SR, Simon L, Biggs P, Jaiswal L, Mohamed B, et al. 2-O, 3-O Desulfated Heparin (ODSH) Preserves Endothelial Barrier Integrity in Lipopolysaccharide-Induced Acute Lung Injury by Modulating TLR4–MyD88–NF-κB Signaling. Biomolecules. 2026. doi:10.3390/biom16101516

BibTeX
@article{Patil2026,
  author = {Patil, Rahul S and Patil, Shweta R and Simon, Liselle and Biggs, Peter and Jaiswal, Latika and Mohamed, Basmah and Kennedy, Thomas P and Gonzales, Joyce and Verin, Alexander D},
  title = {2-O, 3-O Desulfated Heparin (ODSH) Preserves Endothelial Barrier Integrity in Lipopolysaccharide-Induced Acute Lung Injury by Modulating TLR4–MyD88–NF-κB Signaling},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16101516}
}
Kostenlos starten →